EP Patent

EP3255106B1 — A modified collagen

Assigned to Innocoll Pharmaceuticals Ltd · Expires 2019-04-24 · 7y expired

What this patent protects

Patent listed against Bupivacaine Hydrochloride And Epinephrine.

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (Bupivacaine Hydrochloride) · Pfizer

Patent Metadata

Patent number: EP3255106B1
Jurisdiction: EP
Classification: —
Expires: 2019-04-24
Drug substance claim: No
Drug product claim: No
Assignee: Innocoll Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.